SCHEMBL29978698

SCHEMBL29978698

CC1CCN(c2ccc(Cl)cc2N)CC1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.66
ALDH1A1 P00352 5/20 0.64
HTT P42858 4/20 0.64
KDM4E B2RXH2 4/20 0.63
LMNA P02545 3/20 0.63
KMT2A Q03164 3/20 0.60
GAA P10253 2/20 0.60
MEN1 O00255 2/20 0.60
USP2 O75604 1/20 0.60
NR4A1 P22736 1/20 0.60
HSD17B10 Q99714 1/20 0.60
MAPT P10636 3/20 0.56
HPGD P15428 2/20 0.56
NPC1 O15118 1/20 0.56
RAB9A P51151 1/20 0.56
TRPC3 Q13507 1/20 0.47
DRD2 P14416 1/20 0.42
DRD4 P21917 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23043624 1.00 POLB (0.66) POLBALDH1A1HTTKDM4ELMNA
Hydrochloric Acid SCHEMBL27911845 0.89 KDM4E (0.58) POLBALDH1A1HTTKDM4ELMNA
SCHEMBL16146343 0.85 ALDH1A1 (0.65) POLBALDH1A1HTTKDM4ELMNA
SCHEMBL29978565 0.83 KDM4E (0.63) POLBALDH1A1HTTKDM4ELMNA
SCHEMBL359428 0.83 KDM4E (0.63) POLBALDH1A1HTTKDM4ELMNA
SCHEMBL30108222 0.83 ALDH1A1 (0.73) POLBALDH1A1HTTKDM4EKMT2A
SCHEMBL12505512 0.83 POLB (0.60) POLBALDH1A1HTTKDM4ELMNA
SCHEMBL29979084 0.81 HTT (0.68) POLBALDH1A1HTTKDM4ELMNA
SCHEMBL23043725 0.81 HTT (0.68) POLBALDH1A1HTTKDM4ELMNA
SCHEMBL23043687 0.81 GAA (0.62) POLBALDH1A1HTTKDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220315548-A1 SMALL MOLECULE AGONISTS OF MUCOLIPIN 1 AND USES THEREOF NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES 2022-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220315548-A1 SMALL MOLECULE AGONISTS OF MUCOLIPIN 1 AND USES THEREOF MCOLN1, MCOLN2, MCOLN3 POLB 3846/4885ALDH1A1 1368/4885HTT 1333/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.